On September 9, 2024, Taro Pharmaceutical Industries Ltd. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of former shareholders of Taro Pharmaceutical Industries Ltd. in connection with the acquisition (the “Transaction”) of Taro by Sun Pharmaceutical Industries Ltd.

On September 6, 2024, Agenus Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Massachusetts on behalf of investors who purchased or otherwise acquired Agenus securities between January 23, 2023 and July 17, 2024, both dates inclusive (the “Class Period”).

On September 5, 2024, WEBTOON Entertainment Inc. was sued for violations of the federal securities laws in the United States District Court for the Central District of California on behalf of investors who purchased or otherwise acquired Webtoon common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s June 2024 initial public offering (“IPO” or
the “Offering”).

On September 4, 2024, ZoomInfo Technologies, Inc. was sued for violations of the federal securities laws in the United States District Court for the Western District of Washington on behalf of all purchasers of ZoomInfo Class A
common stock between November 10, 2020, and August 5, 2024, both dates inclusive (the “Class Period”).

On September 4, 2024, GitLab Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired GitLab securities between June 6, 2023 and March 4, 2024, inclusive (the “Class Period”).

On August 30, 2024, Migom Global Corp. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who, between December 6, 2019, and August 25, 2022, inclusive (the “Class Period”), purchased or otherwise acquired the securities of Migom Global Corp.

On August 30, 2024, Super Micro Computer, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased the Company’s securities between February 2, 2021 and August 28, 2024, inclusive (the “Class Period”).

On August 29, 2024, Outset Medical, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise
acquired Outset Medical securities between August 1, 2022 and August 7, 2024, inclusive (the “Class Period”).

On August 28, 2024, Sage Therapeutics was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Sage securities between April 12, 2021 and July 23, 2024, both dates inclusive (the “Class Period”).

On August 28, 2024, Starbucks Corporation was sued for violations of the federal securities laws in the United States District Court for the Western District of Washington on behalf of investors who purchased or otherwise acquired Starbucks securities between November 2, 2023 and April 30, 2024, inclusive (the “Class Period”).

On August 27, 2024, Verve Therapeutics, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Massachusetts on behalf of investors who purchased or otherwise acquired publicly traded Verve Therapeutics securities between August 9, 2022 and April 1, 2024, inclusive (the “Class Period”).

On August 26, 2024, Methode Electronics, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of Illinois on behalf of all purchasers of Methode common stock between June 23, 2022 and March 6, 2024, both dates inclusive (the “Class Period”).

On August 26, 2024, Endava, plc was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Endava securities between May 23, 2023, and February 28, 2024, inclusive (the “Class Period”).

On August 23, 2024, STMicroelectronics N.V. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired STM securities between January 25, 2024 to July 24, 2024, inclusive (the “Class Period”).

On August 21, 2024, Orthofix Medical Inc. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of Texas on behalf of investors who purchased or otherwise acquired Orthofix common stock between October 11, 2022, and September 12, 2023, inclusive (the “Class Period”).

On August 21, 2024, DexCom, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of California on behalf of investors who purchased or otherwise acquired DexCom securities between January 8, 2024 to July 25, 2024, inclusive (the “Class Period”).

On August 20, 2024, Spire Global, Inc. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of Virginia on behalf of investors whopurchased or otherwise
acquired Spire Global securities between March 6, 2024 and August 14, 2024, inclusive (the “Class Period”).

On August 16, 2024, Ardelyx, Inc.  was sued for violations of the federal securities laws in the United States District Court for the District of Massachusetts on behalf of investors who purchased or otherwise acquired Ardelyx securities
between October 31, 2023 and July 1, 2024, both dates inclusive (the “Class Period”).

On August 15, 2024, Stellantis N.V. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Stellantis’ securities between February 15, 2024 to July 24, 2024, inclusive (the “Class Period”).

On August 14, 2024, Symbotic Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Massachusetts on behalf of investors who purchased or otherwise acquired SYM securities between May 6, 2024, to July 29, 2024, inclusive (the “Class Period”).